Imidazo ring compounds (e.g., imidazoquinolines, 6,7,8,9-tetrahydroimidazoquinolines, imidazonaphthyridines, and 6,7,8,9-tetrahydroimidazonaphthyridines) with a sulfide-, sulfinyl-, or sulfonyl-containing ether substituent at the 1-position, pharmaceutical compositions containing the compounds, intermediates, methods of making the compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed.
咪唑环化合物(例如
咪唑喹啉,6,7,8,9-四氢
咪唑喹啉,
咪唑萘啉和6,7,8,9-四氢
咪唑萘啉)在1-位置具有含
硫醚,亚砜基或磺酰基的醚取代基,含有这些化合物的药物组合物,中间体,制备这些化合物的方法,以及将这些化合物用作免疫调节剂的方法,用于诱导动物中的细胞因子
生物合成以及治疗包括病毒性和肿瘤性疾病在内的疾病。